VitaTek partners with Merge Medical to collaborate on a podcast featuring Dr. Jeff Brown and Dr. Jeff Cole. Together, they overview the challenges that inspired the development of VitaTek, now the largest private medical device manufacturer in Minnesota with a 150,000 sq ft facility. With a portfolio of 11 medical device products, four are FDA-approved and available on the market (Brekka, StingRay, ClearDropper, and PostRecoveryMD). An additional four devices are scheduled to launch in 2024 (Orchid, LipoShot, Nano Assist, and OctoRetractor).
Make sure to follow our socials to stay up to date on VitaTek news:
My catastrophic experience at Vitatek has been a complete unmitigated disaster, highlighting glaring incompetence in both product development and company culture. The incompetence at the top is a stark reflection of the company's decay, with CEO Jason Scherer displaying an abhorrent obsession with consolidating power at any cost, rather than creating a collaborative and supportive work environment. The ruthless ousting of Justin Barbot, a highly influential and valuable member of the company, exemplifies the repulsive tactics employed by Scherer to assert his dominance. This blatant power play serves as a stark warning sign of a leadership that cares little for the well-being of its employees or the long-term future of the company. It is an ominous portent of instability, chaos,…
vitatek's competitive edge is not pay their sales team, stealing their commissions, and making the engineers work long hours in a hostile work environment.